Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00096694 · ClinicalTrials.gov registry record · NA
Effect of an Intrauterine Contraceptive Device (IUD) in HIV Infected Women
A NA study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
NCT00096694 is a NA study that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 41 participants.
The verdict
NCT00096694, a NA study, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
Study Summary
Oral contraceptives (OCs) are not a good option for some HIV infected women because of the potential for drug interactions between OCs and anti-HIV drugs; additionally, OCs may increase the risk of transmitting HIV to sexual partners. Levonorgestrel is commonly prescribed as part of a combination OC. An intrauterine device (IUD) is a device inserted in a woman's uterus to prevent pregnancy. The purpose of this study is to determine the effect of a levonorgestrel-releasing IUD on the amount of HIV present in an HIV infected woman's cervix after 4 weeks of IUD use. Study hypothesis: There will be no increase in genital tract HIV RNA and DNA after placement of the levonorgestrel IUD.
Interventions
- DEVICE Levonorgestrel-releasing intrauterine device (IUD)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Est. Completion | 2005-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00096694
The ClinicalTrials.gov registry entry for NCT00096694 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Levonorgestrel-releasing intrauterine device (IUD) is the first listed.
NCT00096694 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00096694 about?
NCT00096694 is a clinical study titled "Effect of an Intrauterine Contraceptive Device (IUD) in HIV Infected Women". Oral contraceptives (OCs) are not a good option for some HIV infected women because of the potential for drug interactions between OCs and anti-HIV drugs; additionally, OCs may increase the risk of transmitting HIV to sexual partners. Levonorgestrel is commonly prescribed as part of a combination OC...
What is the current status of trial NCT00096694?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. Estimated completion is 2005-09.
What interventions are being tested in trial NCT00096694?
The interventions under investigation include: Levonorgestrel-releasing intrauterine device (IUD) (DEVICE).
Who is sponsoring clinical trial NCT00096694?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.